PMID: 9169246Jan 1, 1997Paper

A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
D L SultzerM E Mahler

Abstract

The authors compared the efficacy and side effects of trazodone and haloperidol for treating agitated behaviors associated with dementia. Twenty-eight elderly patients with dementia and agitated behaviors were randomly assigned to double-blind treatment with either trazodone (50-250 mg/day) or haloperidol (1-5 mg/day) for 9 weeks. There was no significant difference in improvement between the medication groups. Adverse effects, however, were more common in the group treated with haloperidol. Improvement in individual areas suggested that repetitive, verbally aggressive, and oppositional behaviors responded preferentially to trazodone, whereas symptoms of excessive motor activity and unwarranted accusations responded preferentially to haloperidol. These results indicate that moderate doses of trazodone and haloperidol are equally effective for treatment of overall agitated behaviors in patients with dementia, but specific symptoms may respond preferentially to a particular agent.

Citations

Oct 18, 2008·International Review of Psychiatry·Clive BallardSusanne Sorensen
Jun 2, 2011·Primary Care·David LussierJuan Manuel Villalpando
Dec 2, 2005·Journal of Gerontological Nursing·Philippe VoyerLori Schindel Martin
May 15, 1998·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·H Lavretsky, D Sultzer
Jul 26, 2000·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·J W HawkinsJ A Yesavage
Oct 1, 2007·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Nathan HerrmannPaul G Lysy
Jul 31, 2007·Neurologic Clinics·Brendan J Kelley, Ronald C Petersen
Mar 14, 2007·Journal of the American Medical Directors Association·Barbara J ZarowitzEric G Tangalos
Oct 4, 2007·Journal of the American Geriatrics Society·Denise G FeilDavid Sultzer
Mar 24, 2016·Neurología : publicación oficial de la Sociedad Española de Neurología·E PeñaUNKNOWN en nombre del grupo de trastornos del movimiento de la Asociación Madrileña de Neurología
Jun 9, 1998·The American Journal of Medicine·G W Small
Oct 22, 2005·Lancet Neurology·Ian McKeith, Jeffrey Cummings
Feb 18, 2016·Expert Review of Neurotherapeutics·Radoslaw Magierski, Tomasz Sobow
Mar 18, 2004·Clinics in Geriatric Medicine·Sanford I Finkel
Apr 6, 2004·Clinics in Geriatric Medicine·Kevin F Gray
Oct 22, 2008·Critical Care Clinics·José R Maldonado
Sep 7, 2016·International Journal of Geriatric Psychiatry·Nicolas FarinaSube Banerjee
Nov 28, 2012·BMC Medicine·John C UmhauDavid T George
Jan 1, 1997·New Directions for Mental Health Services·P TariotA P Porsteinsson
Mar 19, 2003·Journal of Geriatric Psychiatry and Neurology·Fadi H RamadanRoger Prior
Jul 27, 2000·Journal of Geriatric Psychiatry and Neurology·K Y KimE Jones
Oct 16, 2010·International Psychogeriatrics·David R Lee, Alan J Thomas
Mar 25, 2011·American Journal of Alzheimer's Disease and Other Dementias·Genevieve HenryRajesh R Tampi
May 7, 1999·Journal of Geriatric Psychiatry and Neurology·B G Pollock, B H Mulsant
Jul 27, 2000·Journal of Geriatric Psychiatry and Neurology·F H RamadanA G Bassanelli
Jan 31, 2012·Dementia and Geriatric Cognitive Disorders·Ton J E M BakkerMiel W Ribbe
Sep 30, 2017·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Adam Gerstenecker
May 17, 2018·Expert Review of Neurotherapeutics·Byron CreeseClive Ballard
Feb 18, 2011·The Cochrane Database of Systematic Reviews·Dallas P SeitzPaula Rochon
Apr 11, 2018·British Journal of Clinical Pharmacology·Khachen KongpakwattanaNathorn Chaiyakunapruk
Sep 25, 2018·Journal of the American Geriatrics Society·Susan E BronskillColleen J Maxwell
Oct 21, 2004·The Cochrane Database of Systematic Reviews·G Martinon-TorresEvans J Grimley
Nov 5, 2003·Expert Opinion on Pharmacotherapy·Hubert H FernandezBrian R Ott
May 23, 2006·Nature Reviews. Neuroscience·Clive Ballard, Robert Howard
Jul 20, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Dilip V JesteKristine Yaffe
Jun 3, 2009·Nature Reviews. Neurology·Clive G BallardConstantine G Lyketsos
Jan 26, 2010·International Psychogeriatrics·Serge GauthierConstantine Lyketsos
Nov 1, 2001·The Cochrane Database of Systematic Reviews·E LonerganJ Colford
Jul 3, 2016·The Cochrane Database of Systematic Reviews·James R SampfordVivek A Furtado

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
H Lavretsky, D L Sultzer
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
A P PorsteinssonS Gaile
© 2021 Meta ULC. All rights reserved